SLC12A5 and neurodevelopmental disorder: It will be of particular interest to examine how KCC2 and NKCC1 expression are altered in patients carrying mutations in the other chromatin regulators and determine how potential disruptions of the GABA-shift may contribute to those neurodevelopmental disorders.